Meanwhile, compared with healthy controls at different stages, such as the acute phase, progressive phase, and convalescent phase, the proportion of Tregs in CD4+ T cells increased in COVID-19 patients, especially in the acute stage and progressive stages (Figure 1E). The gene discussed is CD4; the disease is COVID-19.